Related Experiment Video

Updated: Jul 11, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

A comparison and critical analysis of preclinical anticancer vaccination strategies

J N Kochenderfer1, R E Gress

  • 1Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. kochendj@mail.nih.gov

Experimental Biology and Medicine (Maywood, N.J.)
|September 27, 2007
PubMed

Insights

Anticancer vaccines show promise in animal models but limited success in humans. Strategies using foreign antigens and Interleukin-2, alongside T cell therapies, demonstrated enhanced anticancer activity in B16 melanoma models.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Anticancer vaccines are widely researched, yet clinical efficacy, particularly objective tumor regressions, remains rare.
  • The B16 murine melanoma model is a standard for evaluating diverse anticancer vaccination strategies due to its extensive use.

Purpose of the Study:

  • To review and identify characteristics of vaccination regimens associated with antitumor efficacy using the B16 melanoma model.
  • To compare the effectiveness of different vaccine types and combination therapies.

Main Methods:

  • A review of studies using five common vaccine types (recombinant viral, DNA, dendritic cell, whole-tumor, peptide) against B16 melanoma.
  • Analysis of vaccination combined with adoptive transfer of tumor antigen-specific T cells.

Main Results:

  • Vaccines incorporating xenogeneic (foreign) antigens showed greater anticancer activity than those with syngeneic (self) antigens.
  • Interleukin-2 significantly enhanced the antitumor efficacy of several vaccine types.
  • Effective regimens frequently generated substantial numbers of tumor antigen-specific CD8(+) T cells.

Conclusions:

  • Xenogeneic antigens, Interleukin-2, and generation of CD8(+) T cells are key features associated with effective anticancer vaccination.
  • Identifying these characteristics can guide the development of improved anticancer vaccination strategies.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccinations01:51

Vaccinations

Overview
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...